Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 11, 2000, Pages 1333-1338

  Uno, Koji ^a   Azuma, Takeshi ^b   Nakajima, Masatsugu ^a   Yasuda, Kenjiro ^a   Hayakumo, Takanobu ^a   Mukai, Hidekazu ^c   Sakai, Toshiyuki ^a   Kawai, Keiichi ^a  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c YODOGAWA CHRISTIAN HOSPITAL   (Japan)

Author keywords

Cathepsin E; Pancreatic ductal adenocarcinoma; Pancreatic juice; Tumor marker

Indexed keywords

CATHEPSIN E;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREAS JUICE; PRIORITY JOURNAL;

EID: 0033669914     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02351.x     Document Type: Article

References (25)

1. Endoscopic diagnosis of cancer of the pancreas
2. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas
3. CA494: A new tumor marker for the diagnosis of pancreatic cancer
4. Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancer
5. Serum testosterone: Dihydrotestosterone ratio and CA19-9 in the diagnosis of pancreatic cancer
6. Determination of CA19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis
7. Ductal cancer of the pancreas frequently expresses markers of gastrointestinal epithelial cells
8. Slow moving proteinase: Isolation, characterization, and immunohistochemical localization in gastric mucosa
9. Expression of cathepsin E in pancreas: A possible tumor marker for pancreas, a preliminary report
10. Cathepsins D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: An immunohistochemical study
11. Secretion of human intracellular aspartic proteinase cathepsin E expressed in the methylotrophic yeast, Pichia pastoris and characterization of produced recombinant cathepsin E
12. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA)
13. The meaning and use of the area under a receiver operating characteristic (ROC) curve
14. The diagnostic significance of carbohydrate antigen CA19-9 in serum and pancreatic juice in pancreatic carcinoma
15. Values of CA19-9 in the serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor
16. DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease
17. Elevated pancreatic oncofetal antigen levels measured by enzyme immunoassay in pure pancreatic juice of patients with pancreatic cancer
18. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
19. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas
20. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma
21. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma
22. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice
23. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay
24. Human gastric cathepsin E. Predicted sequence, localization to chromosome 1, and sequence homology with other aspartic proteinases